Vigilant Capital Management, LLC Gilead Sciences, Inc. Transaction History

Vigilant Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$77.31 - $88.08 $46,386 - $52,848	600 New	600 $50,000
Q2 2021 Jul 09, 2021	SELL	$63.47 - $69.35 $6,347 - $6,934	-100 Closed	0 $0
Q3 2020 Oct 15, 2020	SELL	$62.1 - $78.08 $6,210 - $7,808	-100 Reduced 50.0%	100 $6,000
Q4 2019 Jan 17, 2020	BUY	$61.62 - $67.78 $12,324 - $13,556	200 New	200 $13,000
Q2 2019 Jul 18, 2019	SELL	$61.87 - $69.38 $46,526 - $52,173	-752 Closed	0 $0
Q1 2019 Apr 09, 2019	SELL	$62.53 - $70.05 $212,852 - $238,450	-3,404 Reduced 81.91%	752 $49,000
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $33,418 - $43,608	-552 Reduced 11.72%	4,156 $260,000
Q3 2018 Oct 11, 2018	SELL	$71.28 - $78.92 $47,472 - $52,560	-666 Reduced 12.39%	4,708 $364,000
Q2 2018 Jul 11, 2018	SELL	$64.88 - $75.68 $62,803 - $73,258	-968 Reduced 15.26%	5,374 $381,000
Q1 2018 Apr 04, 2018	SELL	$72.84 - $88.8 $509 - $621	-7 Reduced 0.11%	6,342 $478,000
Q4 2017 Jan 31, 2018	BUY	$71.15 - $83.52 $156,316 - $183,493	2,197 Added 52.91%	6,349 $455,000
Q3 2017 Oct 13, 2017	BUY	$72.11 - $85.47 $299,400 - $354,871	4,152	4,152 $336,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vigilant Capital Management, LLC with notifications on news.